Pharmacelera raises €6M to expand in U.S. and build out its high speed, high accuracy, deep tech drug discovery platform

Demo]---- -- is an independent alternative asset management firm specialized in innovative projects and industrial SMEs. The firm has extensive experience in creating business value from scientific research results, with more than 20 years of expertise in investing, building, and supporting technology projects from their early stages, with a clear focus on technology transfer. Currently, the firm manages €173 million, with a highlight being Clave Innohealth F.C.R., a €50 million fund specialized in medical ...